ALNYLAM

Serial Number 87927601
Registration 6739619
700

Registration Progress

Application Filed
May 18, 2018
Under Examination
Apr 9, 2019
Approved for Publication
Feb 12, 2019
Published for Opposition
Feb 12, 2019
Registered
May 24, 2022

Trademark Image

ALNYLAM

Basic Information

Serial Number
87927601
Registration Number
6739619
Filing Date
May 18, 2018
Registration Date
May 24, 2022
Published for Opposition
February 12, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 24, 2022
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
675 West Kendall Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Deadline
1028 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-05-24)
Due Date
May 24, 2028
Grace Period Ends
November 24, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

46 events
Date Code Type Description Documents
Mar 30, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 30, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 30, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 25, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 24, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 21, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 20, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 19, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 8, 2022 IUAF S USE AMENDMENT FILED Loading...
Apr 8, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 15, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 15, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 9, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 13, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 9, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 9, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 9, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 7, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 7, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 7, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 1, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 30, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 30, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 30, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 11, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 9, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 9, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 9, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 9, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 12, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 12, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 23, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 7, 2019 ALIE A ASSIGNED TO LIE Loading...
Dec 12, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 12, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 12, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 12, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 19, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 19, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 19, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 11, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
May 26, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 22, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1, Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), porphyria, hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1
First Use Anywhere: 20180900
First Use in Commerce: 20180900

Classification

International Classes
005